Resveratrol

Resveratrol is being investigated across multiple therapeutic areas, though the clinical evidence remains limited compared to preclinical research.

Neurological Conditions

Recent research has explored resveratrol's potential neuroprotective properties. One 2026 study investigated a combination therapy including resveratrol for Alzheimer's disease, examining its effects on hippocampal damage in experimental models. Another study published the same year examined resveratrol's role in epilepsy-induced brain damage, suggesting it may work through the P62-Keap1-Nrf2 pathway. Research has also looked at resveratrol's activation of Nrf2 pathways as a potential treatment approach for Parkinson's disease.

However, these findings are primarily from preclinical studies. Clinical evidence for neurological applications remains sparse.

Metabolic and Age-Related Health

A completed Phase 2 clinical trial (NCT02123121) titled "Resveratrol to Enhance Vitality and Vigor in Elders" investigated resveratrol's effects on aging-related parameters, though specific results are not detailed in the available evidence. Another completed study (NCT02381145) examined dietary polyphenols, including resveratrol, for insulin sensitivity in overweight and obese individuals.

Cardiovascular Applications

Research has examined resveratrol's potential cardioprotective effects, particularly regarding doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury. A 2026 study explored how natural compounds including resveratrol might modulate ion channels for cardiac therapeutics through molecular modeling approaches.

Other Applications

Additional research areas include:

• Ophthalmic conditions: A 2026 study developed dissolving microneedle patches containing resveratrol for corneal anti-angiogenic therapy
• HIV treatment: One completed trial (NCT04386499) examined biological effects of resveratrol in patients receiving antiretroviral therapy
• Allergic diseases: Research has investigated resveratrol's potential to inhibit pathological IgE in allergic conditions

Clinical Evidence Limitations

The clinical evidence for resveratrol remains limited. While multiple completed clinical trials are listed, detailed results and efficacy data are not provided in the available evidence. Most research appears to be in early phases or focuses on mechanistic studies rather than definitive therapeutic outcomes.

Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using resveratrol for any medical condition.